Telmisartan is a medication used to treat high blood pressure, heart failure, and other cardiovascular conditions. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels and improving blood flow.
The global market for telmisartan is driven by a growing incidence of hypertension and other cardiovascular diseases, as well as increasing demand for effective and affordable treatments. According to a report by ResearchAndMarkets.com, the global telmisartan market was valued at $2.2 billion in 2020 and is expected to reach $2.9 billion by 2026, growing at a CAGR of 4.3% during the forecast period.
North America and Europe are the largest markets for telmisartan, due to high prevalence of hypertension and robust healthcare infrastructure. However, the Asia Pacific region is expected to witness the fastest growth, owing to a large patient population, increasing healthcare expenditure, and rising awareness about the benefits of ARBs.
To Get Details :
https://analyticsmarketresearch.com/reports/telmisartan-market/15924/ Telmisartan is a medication used to treat high blood pressure, heart failure, and other cardiovascular conditions. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels and improving blood flow.
The global market for telmisartan is driven by a growing incidence of hypertension and other cardiovascular diseases, as well as increasing demand for effective and affordable treatments. According to a report by ResearchAndMarkets.com, the global telmisartan market was valued at $2.2 billion in 2020 and is expected to reach $2.9 billion by 2026, growing at a CAGR of 4.3% during the forecast period.
North America and Europe are the largest markets for telmisartan, due to high prevalence of hypertension and robust healthcare infrastructure. However, the Asia Pacific region is expected to witness the fastest growth, owing to a large patient population, increasing healthcare expenditure, and rising awareness about the benefits of ARBs.
To Get Details : https://analyticsmarketresearch.com/reports/telmisartan-market/15924/